These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17394878)

  • 1. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.
    Rottbauer W; Gautel M; Zehelein J; Labeit S; Franz WM; Fischer C; Vollrath B; Mall G; Dietz R; Kübler W; Katus HA
    J Clin Invest; 1997 Jul; 100(2):475-82. PubMed ID: 9218526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.
    Hirota T; Kubo T; Kitaoka H; Hamada T; Baba Y; Hayato K; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Doi YL
    J Cardiol; 2010 Jul; 56(1):59-65. PubMed ID: 20350521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy.
    Meurs KM; Norgard MM; Ederer MM; Hendrix KP; Kittleson MD
    Genomics; 2007 Aug; 90(2):261-4. PubMed ID: 17521870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish.
    Zahka K; Kalidas K; Simpson MA; Cross H; Keller BB; Galambos C; Gurtz K; Patton MA; Crosby AH
    Heart; 2008 Oct; 94(10):1326-30. PubMed ID: 18467358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
    Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
    Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
    Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
    Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
    Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
    Page SP; Kounas S; Syrris P; Christiansen M; Frank-Hansen R; Andersen PS; Elliott PM; McKenna WJ
    Circ Cardiovasc Genet; 2012 Apr; 5(2):156-66. PubMed ID: 22267749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.